Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Oct 29, 2013
Filed with the SEC on Oct 29, 2013 and accepted by EDGAR at Oct 29, 2013, 12:18 ET.
Items reported
- Item 2.02 Results of operations
- Item 2.05 Exit or disposal costs
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000875320-13-000042. Last ingested by Listed: Nov 11, 2026, 01:11 ET. Listed shows no prices and gives no investment advice.